Skandinaviska Enskilda Banken Ab (Publ) Bio Rad Laboratories, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.6 Billion
- Q4 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 3,731 shares of BIO stock, worth $989,311. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,731
Previous 3,831
2.61%
Holding current value
$989,311
Previous $1.28 Million
4.37%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding BIO
# of Institutions
479Shares Held
19.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$509 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$411 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$277 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$259 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$198 Million0.06% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.53B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...